Skip to main content
. 2019 Nov 15;9:16929. doi: 10.1038/s41598-019-53073-w

Figure 3.

Figure 3

MEDs that significantly discriminated the two groups –patients that did not develop ulcerative oral mucositis (green) and patients that did develop ulcerative oral mucositis (red) before autoSCT (biomarker identification tool LEfSe, p < 0.05, LDA > 2).